ESC 365 - Downstream or upstream P2Y12 receptor blockers in NSTE-ACS

ESC Premium Access

Downstream or upstream P2Y12 receptor blockers in NSTE-ACS

Session: Latest Randomized Results on Antiplatelet Therapy

Topic: Pharmacotherapy

Speaker: Associate Professor G. Tarantini (Padova, IT)

Event: ESC Congress 2020

Congress Presentation

About the speaker

Associate Professor Giuseppe Tarantini

University of Padua, Padova (Italy)

9 presentations

1 follower

3 more presentations in this session

Online session - Latest Randomized Results on Antiplatelet Therapy - Host and Discussant

Speaker: Professor M. Roffi (Geneva, CH)

The effect of one year postoperative ticagrelor in addition to aspirin on saphenous vein graft patency in patients undergoing CABG – a randomized, multi-center, double-blind, placebo-controlled trial.

Speaker: Miss L. Willemsen (Nieuwegein, NL)

Prasugrel based de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial

Speaker: Doctor H. Kim (Seoul, KR)

Access the full session

Latest Randomized Results on Antiplatelet Therapy

Speakers: Associate Professor G. Tarantini, Professor M. Roffi, Miss L. Willemsen, Doctor H. Kim

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by